dopa造句
1, They were then given L - DOPA or a placebo and asked to imagine holidaying in those destinations.
2, Clinical treatment of PD includes dopamine replacement such as L - DOPA and D _ 2 dopamine receptor agonist.
3, Conclusions Asimpleandpracticaltechniqueisprovidedfortheradiochemicalsynthesisof 6 1 8 F DOPA . Thesynthetic 6 1 8 F DOPAisallowedtobeusedtostudytheanimalandParkinson'sdiseasewithPETimaging.
4, Keywords: plant cell culture, L - DOPA, agitated reactor, operation strategy, scale - up.
5, Neuroblastomas also associated with increased urinary levels of dopa, dopamine and their metabolites, particularly homovanillis acid.
6, Objective To introduce L dopa test into the preparation of the surgical intervention of PD.
7, Objective To analyze the clinical characteristics of dopa - responsive dystonia ( DRD ).
8, High concentrations of L - DOPA and dopamine are toxic to the larvae.
9, Conclusions L dopa induced dyskinesia may disappear or be improved after PVP.
10, The molconvert ratio of L - DOPA was 82.8 % from catechol.
11, Mothods L dopa tests were conducted in 33 cases with PD, after UPDRS rating and Webster rating.
12, Objective To study the neurotoxicity of L dopa and its neuroprotective method.
13, Objective To summarize the clinical characteristics of dopa - responsive dystonia ( DRD ).
14, Using L - dihydroxyphenylalanine ( L - DOPA ) as substrate,[http:///dopa.html] the highest PO activity is under the conditions of pH 6.5 and 40 ℃.
15, Objective To explore the pathogeny, clinical characteristics and therapy of dopa - responsive dystonia ( DRD ).
16, Methods: Tyrosinase activity in vitro was measured by the rate of oxidation of L - Dopa.
17, Neuroblastomas are also associated with increased urinary levels of dopa, dopamine and their metabolites.
18, Objective To investigate the clinical characteristics and GCHgene mutations in patients with dopa - responsive dystonia ( DRD ).
19, Objective To study the clinical characteristics of patients with dopa - responsive dystonia ( DRD ).
20, AIM The purpose is to synthesize 6 fluoro L DOPA ( FDOPA ).
21, DOPA staining: The staining was performed with 0.1 % L - DOPA solution in frozen sections.
22, Objective To explore the clinical feature and treatment method of the dopa responsive dystonia ( DRD ).